UBS Group’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $7.71M | Buy |
|
|||||
|
2022
Q4 | $457K | Buy |
|
|||||
|
2022
Q3 | $144K | Sell |
|
|||||
|
2022
Q2 | $129K | Sell |
|
|||||
|
2022
Q1 | $261K | Sell |
|
|||||
|
2021
Q4 | $213K | Buy |
|
|||||
|
2021
Q3 | $221K | Sell |
|
|||||
|
2021
Q2 | $312K | Sell |
|
|||||
|
2021
Q1 | $483K | Buy |
|
|||||
|
2020
Q4 | $593K | Sell |
|
|||||
|
2020
Q3 | $551K | Sell |
|
|||||
|
2020
Q2 | $660K | Buy |
|
|||||
|
2020
Q1 | $238K | Buy |
|
|||||
|
2019
Q4 | $311K | Buy |
|
|||||
|
2019
Q3 | $84K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $11K | Buy |
|